Barclays Maintains Overweight on MetLife, Lowers Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Alex Scott maintains an Overweight rating on MetLife (NYSE:MET) but lowers the price target from $91 to $90.

October 31, 2024 | 6:22 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Alex Scott maintains an Overweight rating on MetLife but slightly lowers the price target from $91 to $90.
The Overweight rating suggests a positive outlook, but the slight reduction in the price target indicates a minor adjustment in expectations. This is likely to have a neutral short-term impact on the stock price as the overall sentiment remains positive.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100